Anthera Pharma (ANTH) Tops Q1 EPS by 3c

Anthera Pharma (NASDAQ: ANTH) reported Q1 EPS of ($0.28), $0.03 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Anthera Pharma (ANTH) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Ross Stores raises 2026 outlook after strong second-quarter results
• Holcim to acquire Fermacell from James Hardie for EUR 840M